Dr. Michael Joseph Beckman, MD

Dr. Beckman practices at Atrium Health Cabarrus in Concord, North Carolina, part of Advocate Health.

Dr. Beckman's NPI, 1245526920, was assigned on June 22, 2011. Dr. Beckman graduated from State University of New York Downstate Medical Center in 2011. Dr. Beckman holds North Carolina license 2020-03118.

Dr. Beckman's primary practice is Atrium Health Cabarrus, at 920 Church St N, Concord, NC 28025 in Cabarrus County. The practice phone is (704) 783-3000.

Dr. Beckman's primary practice is Atrium Health Cabarrus in Concord, North Carolina, part of Advocate Health. Dr. Beckman is also affiliated with Atrium Health Carolinas Medical Center. The medical group on file is Atrium Health Cleveland Imaging. Dmand AI also links Dr. Beckman to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Beckman practices, 5 sites in all. Vendor and product names are available with a free account.

Surgical oncology is Dr. Beckman's primary specialty in the NPI Registry, under taxonomy code 2086X0206X. Dr. Beckman is licensed in North Carolina.

CMS data shows 113 Medicare services from Dr. Beckman across 6 procedure codes in 2024, for 90 Medicare patients. Medicare paid $9,404 for them.

CMS counts 90 Medicare patients who saw Dr. Beckman in 2024. The largest group is 65 to 74, with 44 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 12% are also on Medicaid. Their average risk score is 1.68, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Beckman's median patient age at 70, with 47% women.

In 2017, Dr. Beckman wrote 14 Medicare Part D claims. They cover 1 drug, with $87 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Beckman for performance year 2024, reported through an alternative payment model (APM). Dr. Beckman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Beckman as offering telehealth.

Dmand AI links 16 papers to Dr. Beckman, published from 2014 to 2023. 2023 was the busiest year, with 4. The most frequent topics are Imatinib Mesylate, Macrophages and Postoperative Complications. Dr. Beckman has published most often in Clin Cancer Res. Dr. Beckman's most frequent co-authors are Ronald P. Dematteo, MD, Michael Ross Driedger, MD and John Bennett Martinie, MD.

CMS Open Payments shows 18 general payments to Dr. Beckman from 7 drug and device companies from 2016 to 2025. Education make up the largest share, 68% of the total. Intuitive Surgical, Inc. paid the most, $3,634.

Dr. Beckman graduated from State University of New York Downstate Medical Center in 2011.